Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.48 USD | -1.60% | -3.33% | -17.46% |
May. 29 | Premier Insider Sold Shares Worth $253,042, According to a Recent SEC Filing | MT |
May. 28 | JPMorgan Adjusts Price Target on Premier to $21 From $23, Maintains Neutral Rating | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.46% | 1.97B | B- | ||
-1.66% | 187B | C+ | ||
+1.05% | 110B | C | ||
-2.21% | 69.54B | A | ||
+13.07% | 46.37B | B- | ||
-6.62% | 46.05B | B- | ||
+7.97% | 42.54B | B+ | ||
+17.26% | 30.72B | B | ||
+17.70% | 25.62B | A- | ||
-7.06% | 23.32B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PINC Stock
- Ratings Premier, Inc.